Ani Pharmaceuticals (ANIP) Net Equity Issued and Repurchased (2010 - 2012)

Ani Pharmaceuticals has reported Net Equity Issued and Repurchased for 3 years, with the latest figure at -$7933.0 in Q4 2012.

• Quarterly Net Equity Issued and Repurchased changed N/A year-over-year to -$7933.0 in Q4 2012, while the trailing twelve-month figure through Sep 2023 was -$7933.0 (down 183.66% YoY) and the FY2023 annual result came in at $80.6 million, changed N/A from the prior year.
• Net Equity Issued and Repurchased fell to -$7933.0 in Q4 2012 per ANIP's latest filing, from $17415.0 in the prior quarter.
• Over five years, Net Equity Issued and Repurchased peaked at $23.9 million in Q1 2011 and troughed at -$41045.0 in Q2 2011.
• A 3-year average of $6.8 million and a median of $8575.5 in 2010 frame the typical range for Net Equity Issued and Repurchased.
• The widest YoY moves for Net Equity Issued and Repurchased: up 6696.59% in 2011, down 6696.59% in 2011.
• Over 3 years, Net Equity Issued and Repurchased stood at $16.9 million in 2010, then plunged by 99.9% to $17415.0 in 2011, then tumbled by 145.55% to -$7933.0 in 2012.
• According to Business Quant data, Net Equity Issued and Repurchased over the past three periods registered -$7933.0, $17415.0, and -$41045.0 for Q4 2012, Q3 2011, and Q2 2011 respectively.